CRSP Exercise Disclosure
Kulkarni Samarth · SEC Form 4 · Filed Oct 20, 2026
Exercise
Reported value range
Not reported
Kulkarni Samarth Chief Executive Officer
CRSP
Transaction date
Oct 16, 2026
Public filing date
Oct 20, 2026
Filing lag
Filed 4 days later
CRSP daily price context
Close on/before transaction
$49.25
Oct 16, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Shares
- Quantity / price
- 100,000 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-426878
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$2.38M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crispr Therapeutics Ag CRSP | Sale | Oct 19, 2026 | $2.38M |
| Crispr Therapeutics Ag CRSP Current | Exercise | Oct 16, 2026 | Not reported |
| Crispr Therapeutics Ag CRSP | Exercise | Oct 16, 2026 | Not reported |